-
1 Comment
Avecho Biotechnology Limited is currently in a long term downtrend where the price is trading 4.4% below its 200 day moving average.
From a valuation standpoint, the stock is 64.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 91.0.
Avecho Biotechnology Limited's total revenue rose by 203.0% to $188K since the same quarter in the previous year.
Its net income has dropped by 21.1% to $-2M since the same quarter in the previous year.
Finally, its free cash flow grew by 56.5% to $-311K since the same quarter in the previous year.
Based on the above factors, Avecho Biotechnology Limited gets an overall score of 3/5.
| Industry | Biotechnology |
|---|---|
| ISIN | AU0000047441 |
| Exchange | AU |
| CurrencyCode | AUD |
| Sector | Healthcare |
| Target Price | 1.72 |
|---|---|
| Market Cap | 13M |
| PE Ratio | None |
| Beta | 1.12 |
| Dividend Yield | None |
Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, the Americas, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery. Its human health portfolio covers delivery of pharmaceutical products for pain and dermatology applications through gels, injectables, and patches. In addition, the company develops pharmaceutical products; oral, topical, and edible pharmaceutical cannabinoid products, including a cannabidiol TPM soft-gel capsule in Phase III clinical trial for the treatment of insomnia; and non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for AVE.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
